J. Scott Sawyer
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Chemical Synthesis and Reactions, Asthma and respiratory diseases, TGF-β signaling in diseases, Chemical Synthesis and Analysis, Asymmetric Synthesis and Catalysis
Most-Cited Works
- → Development of TGF-β signalling inhibitors for cancer therapy(2004)546 cited
- → Recent Advances in Diaryl Ether Synthesis(2000)305 cited
- → Synthesis and Activity of New Aryl- and Heteroaryl-Substituted Pyrazole Inhibitors of the Transforming Growth Factor-β Type I Receptor Kinase Domain(2003)237 cited
- → Preclinical assessment of galunisertib (LY2157299 monohydrate), a first-in-class transforming growth factor-β receptor type I inhibitor(2017)170 cited
- → Physical properties and synthetic utility of .alpha.-alkoxyorganolithium species as studied through ligand selectivity in tin-lithium exchange(1988)164 cited
- → Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-β type I receptor kinase domain(2004)162 cited
- → Kinase requirements in human cells: III. Altered kinase requirements inVHL−/− cancer cells detected in a pilot synthetic lethal screen(2008)141 cited
- → Synthesis of Diaryl Ethers, Diaryl Thioethers, and Diarylamines Mediated by Potassium Fluoride−Alumina and 18-Crown-6: Expansion of Scope and Utility1(1998)131 cited
- → High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy(2011)108 cited
- → Kinetic Characterization of Novel Pyrazole TGF-β Receptor I Kinase Inhibitors and Their Blockade of the Epithelial−Mesenchymal Transition(2005)99 cited